A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT04761627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blinded Study Evaluating the Pharmacokinetics, Efficacy and Safety of Multiple Switches Between Ustekinumab and ABP 654 Compared With Continued Use of Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis
Study identification
- NCT ID
- NCT04761627
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 494 participants
Conditions and interventions
Conditions
Interventions
- Ustekinumab Drug
- ABP 654 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2021
- Primary completion
- Feb 27, 2023
- Completion
- Feb 27, 2023
- Last update posted
- Jan 10, 2024
2021 – 2023
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Zenith Research Inc. | Beverly Hills | California | 90212 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Quest Dermatology Research | Northridge | California | 91324-4669 | — |
| Southern California Dermatology, Inc | Santa Ana | California | 92701 | — |
| Encore Research Group-Jacksonville Center for Clinical Resea | Jacksonville | Florida | 32216 | — |
| Altus Research, Inc. | Lake Worth | Florida | 33461 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| Leavitt Medical Associates of Florida d/b/a Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Riverchase Dermatology and Cosmetic Surgery | Pembroke Pines | Florida | 33028-1013 | — |
| Olympian Clinical Research | Tampa | Florida | 33614 | — |
| Hamilton Research, LLC | Alpharetta | Georgia | 30022 | — |
| Advanced Medical Research PC | Sandy Springs | Georgia | 30328 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| DS Research | Clarksville | Indiana | 47129 | — |
| Integrated Clinical Trial Services Inc. | West Des Moines | Iowa | 50265 | — |
| Kansas Medical Clinic, PA | Topeka | Kansas | 66614 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Skin Specialists PC | Omaha | Nebraska | 68144 | — |
| ActivMed Practices & Research, LLC. | Portsmouth | New Hampshire | 03801 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| The Dermatology Group, PC | Verona | New Jersey | 07044 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28405 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Austin Institute for Clinical Research, Inc. | Dripping Springs | Texas | 78620 | — |
| Austin Institute for Clinical Research, Inc - Dermatology | Pflugerville | Texas | 78660 | — |
| Progressive Clinical Research [Texas] | San Antonio | Texas | 78213 | — |
| Center for Clinical Studies, LTD., LLP | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04761627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04761627 live on ClinicalTrials.gov.